Back | Next |
home / stock / phvs / phvs message board
Subject | By | Source | When |
---|---|---|---|
Yeah looking great my average now ist even | europtiger | investorshub | 12/29/2022 3:41:30 PM |
Your doing great closed $11.20 :) | subslover | investorshub | 12/28/2022 10:00:44 PM |
So I got now average 8,80$ Lets see I guess | europtiger | investorshub | 12/12/2022 1:49:45 PM |
What going on back to 7 | Pt3 | investorshub | 12/09/2022 9:16:16 PM |
??? | winna | investorshub | 12/09/2022 7:32:38 PM |
Ez hold. Down 12% and you think its | MT101 | investorshub | 12/09/2022 3:56:58 PM |
You were saying? | winna | investorshub | 12/09/2022 3:56:13 PM |
$PHVS: RED prices at morning, sailors take warni | Invest-in-America | investorshub | 12/09/2022 3:27:09 PM |
$PHVS:: Were you referring to YOURSELF, Sir, with | Invest-in-America | investorshub | 12/09/2022 3:16:17 PM |
$PHVS: Where have all the smart-ass, know-it-all's gone??????? | Invest-in-America | investorshub | 12/09/2022 3:00:28 PM |
$PHVS: The RED PRICE will edify you today | Invest-in-America | investorshub | 12/09/2022 2:40:20 PM |
I actually just loaded every more in PM. | MT101 | investorshub | 12/09/2022 2:25:50 PM |
It is going NOWHERE, Dude. It had its | Invest-in-America | investorshub | 12/09/2022 2:18:24 PM |
Everything your saying is false. I sure hope | MT101 | investorshub | 12/09/2022 2:14:37 PM |
Shorts are trapped this is $HKD 2.0 | MT101 | investorshub | 12/09/2022 2:11:26 PM |
$PHVS: It was a monster runner, that's for | Invest-in-America | investorshub | 12/09/2022 2:06:50 PM |
PHVS: I do NOT own any of this. | Invest-in-America | investorshub | 12/09/2022 2:04:12 PM |
Lol your going to lose your entire portfolio | MT101 | investorshub | 12/09/2022 4:12:09 AM |
They will try but the buying pressure is | MT101 | investorshub | 12/09/2022 4:10:47 AM |
Agree best to wait for pop tomorrow then | doebop | investorshub | 12/09/2022 3:22:15 AM |
News, Short Squeeze, Breakout and More Instantly...
Pharvaris N.V. Company Name:
PHVS Stock Symbol:
NASDAQ Market:
ZUG, Switzerland, May 13, 2024 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral bradyk...
ZUG, Switzerland, May 13, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, today announced the acceptance of abstracts for presentation ...
RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, currently enrolling End-of-Phase 2 meeting scheduled to discuss development plan of deucrictibant for the prophylaxis of HAE attacks Executing from a strong financial position with cash a...